Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NCCAM Statement on Presentation of GAIT Results at ACR Meeting
NCCAM and our NIH study co-sponsor, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, are refraining from comment on the study until the full results are published in the peer-reviewed literature.
- NCCAM Statement on Presentation of GAIT Results at ACR Meeting
NCCAM and our NIH study co-sponsor, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, are refraining from comment on the study until the full results are published in the peer-reviewed literature.
- NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain
Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis.
- NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain
Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis.
- NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain
Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis.
- NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain
Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis.
- NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain
Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis.
- New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes
Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells.
- New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes
Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells.
- New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes
Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells.
- New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes
Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells.
- New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes
Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells.
- Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study
A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total
- Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study
A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total
- Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study
A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total
- Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study
A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total
- Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study
A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total
- Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study
A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total
- Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study
A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total
- Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study
A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- New Study Indicates That ChromeMate(R) Increases Lifespan of Test Animals
A study, conducted by researchers at Georgetown University Medical Center (Washington, DC) and Creighton University Medical Center (Omaha, NE), presented at the Annual Meeting of the American College of Nutrition, indicates that rats fed a diet supplemented with ChromeMate (oxygen-coordinated, niacin-bound chromium) had an average lifespan that was 22% greater than rats fed the same diet without supplementation.
- New Study Indicates That ChromeMate(R) Increases Lifespan of Test Animals
A study, conducted by researchers at Georgetown University Medical Center (Washington, DC) and Creighton University Medical Center (Omaha, NE), presented at the Annual Meeting of the American College of Nutrition, indicates that rats fed a diet supplemented with ChromeMate (oxygen-coordinated, niacin-bound chromium) had an average lifespan that was 22% greater than rats fed the same diet without supplementation.
- Herb Science Group’s Letter Regarding Low Dosage in Echinacea Trial Published in New England Journal of Medicine
The New England Journal of Medicine [NEJM] has published a letter to the editor from the American Botanical Council (written by ABC Founder and Executive Director Mark Blumenthal and Norman R. Farnsworth, PhD, Research Professor of Pharmacognosy and Senior University Scholar at the College of Pharmacy at the University of Illinois at Chicago) regarding the low dosage of Echinacea extracts used in a recent clinical trial. The letter suggested that the dosage administered in the trial may have been too low to produce an appreciable benefit.
- Herb Science Group’s Letter Regarding Low Dosage in Echinacea Trial Published in New England Journal of Medicine
The New England Journal of Medicine [NEJM] has published a letter to the editor from the American Botanical Council (written by ABC Founder and Executive Director Mark Blumenthal and Norman R. Farnsworth, PhD, Research Professor of Pharmacognosy and Senior University Scholar at the College of Pharmacy at the University of Illinois at Chicago) regarding the low dosage of Echinacea extracts used in a recent clinical trial. The letter suggested that the dosage administered in the trial may have been too low to produce an appreciable benefit.
- Herb Science Group’s Letter Regarding Low Dosage in Echinacea Trial Published in New England Journal of Medicine
The New England Journal of Medicine [NEJM] has published a letter to the editor from the American Botanical Council (written by ABC Founder and Executive Director Mark Blumenthal and Norman R. Farnsworth, PhD, Research Professor of Pharmacognosy and Senior University Scholar at the College of Pharmacy at the University of Illinois at Chicago) regarding the low dosage of Echinacea extracts used in a recent clinical trial. The letter suggested that the dosage administered in the trial may have been too low to produce an appreciable benefit.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass
According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin.
- Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass
According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin.
- Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass
According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin.
- Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass
According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol
Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States.
- Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol
Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States.
- Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol
Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States.
- Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol
Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States.
- Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol
Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States.
- Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol
Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States.
- Study Examines Ability of Vitamin To Help Treatment-resistant Asthma
Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks.
- Study Examines Ability of Vitamin To Help Treatment-resistant Asthma
Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks.
- Study Examines Ability of Vitamin To Help Treatment-resistant Asthma
Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- NPI Daily - Top of The News for January 8, 2009 - HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America
Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension; BBB Warns Consumers of Two Companies That Use Oprah, Other Celebrity Names, to Sell Supplements; HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America; dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD; Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink; Health Canada Releases January 2009 Issue of CARN; What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
- NPI Daily - Top of The News for January 8, 2009 - HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America
Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension; BBB Warns Consumers of Two Companies That Use Oprah, Other Celebrity Names, to Sell Supplements; HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America; dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD; Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink; Health Canada Releases January 2009 Issue of CARN; What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
|
Green Bay, WI (November 21, 2005) – A recent study involving LitoZin®, the newest generation of joint health supplements, will be presented at the Osteoarthritis Research Society International World Congress in Boston, Massachusetts on December 8, 2005. The study’s principal author, Dr Kaj Winther, will present a poster detailing the effect of Litozin on decreasing cholesterol levels, as well as alleviating symptoms of osteoarthritis.
The study, published recently in the Scandinavian Journal of Rheumatology, demonstrates that there was a significant reduction, 82%, in joint discomfort after 3 weeks of treatment with LitoZin®. Additionally, the consumption of rescue medicine also declined significantly in the active treatment group. WOMAC pain significantly declined (p<0.02) as compared to placebo, after 3 weeks of treatment. The study’s results support the findings on earlier clinical studies published by the same group as well as studies by other independent groups. The study also demonstrated significant decline in cholesterol levels (p<0.05), which is the subject of Dr Winther’s poster presentation.
This most recent study, A powder made from seeds and shells of a rose-hip subspecies (Rosa canina l.) reduces symptoms of knee and hip osteoarthritis: A randomized, double-blind, placebo-controlled clinical trial, Scand J Rheumatol 34:302-308, 2005 by Winther, K. Apel, K and Thomsborg,G., is the continuation of an extensive series of laboratory and clinical investigations on anti-inflammatory and efficacy of rose hip in osteoarthritis. The Scandinavian Journal of Rheumatology is one of the leading international journals in the field of arthritis and rheumatology.
The proprietary extract, made from a unique Danish wild rose hip, subspecies rosa canina lito, is being imported into the US by Terry Lemerond, a pioneer in discovering and bringing to North America natural dietary supplements with significant research behind them. Lemerond’s company, EuroPharma, has secured the North American rights to LitoZin® and is in talks with partner companies to market Litozin in the US.
Located in Green Bay, Wisconsin, EuroPharma, Inc., is committed to discovering innovative products that have been extensively researched and demonstrated to be safe, natural and effective which will help people live healthier and more fulfilling lives. EuroPharma’s mission is to bring truly unique and industry changing products to the U.S. marketplace. EuroPharma is an extension of its founder, Terry Lemerond’s historic successes and a proven model of product development. For more information, visit www.EuroPharmaUSA.com.
– END
Contact:
Suzanne Shelton
847-676-4337
Suzanne@SheltonGroupPR.com |